Kalemkerian GP - Search Results

1

Phase II study of hyperfractionated radiotherapy and concurrent weekly alternating chemotherapy in limited-stage small cell lung cancer.

Ali MA, Kraut MJ, Valdivieso M, Herskovic AM, Du W, Kalemkerian GP. Ali MA, et al. Among authors: kalemkerian gp. Lung Cancer. 1998 Oct;22(1):39-44. doi: 10.1016/s0169-5002(98)00064-6. Lung Cancer. 1998. PMID: 9869106 Clinical Trial.

2

Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.

Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S, Mabry M. Kalemkerian GP, et al. J Natl Cancer Inst. 1995 Nov 15;87(22):1674-80. doi: 10.1093/jnci/87.22.1674. J Natl Cancer Inst. 1995. PMID: 7473815

3

Lung cancer in young patients: analysis of a Surveillance, Epidemiology, and End Results database.

Ramalingam S, Pawlish K, Gadgeel S, Demers R, Kalemkerian GP. Ramalingam S, et al. Among authors: kalemkerian gp. J Clin Oncol. 1998 Feb;16(2):651-7. doi: 10.1200/JCO.1998.16.2.651. J Clin Oncol. 1998. PMID: 9469354

4

Dolastatin 15 induces apoptosis and BCL-2 phosphorylation in small cell lung cancer cell lines.

Ali MA, Rosati R, Pettit GR, Kalemkerian GP. Ali MA, et al. Among authors: kalemkerian gp. Anticancer Res. 1998 Mar-Apr;18(2A):1021-6. Anticancer Res. 1998. PMID: 9615758

5

Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer.

Joshi US, Chen YQ, Kalemkerian GP, Adil MR, Kraut M, Sarkar FH. Joshi US, et al. Among authors: kalemkerian gp. Cancer Gene Ther. 1998 May-Jun;5(3):183-91. Cancer Gene Ther. 1998. PMID: 9622102

6

A phase II study of all-trans-retinoic acid plus cisplatin and etoposide in patients with extensive stage small cell lung carcinoma: an Eastern Cooperative Oncology Group Study.

Kalemkerian GP, Jiroutek M, Ettinger DS, Dorighi JA, Johnson DH, Mabry M. Kalemkerian GP, et al. Cancer. 1998 Sep 15;83(6):1102-8. doi: 10.1002/(sici)1097-0142(19980915)83:6<1102::aid-cncr8>3.0.co;2-9. Cancer. 1998. PMID: 9740074 Clinical Trial.

7

Induction of apoptosis by a short-chain neuropeptide analog in small cell lung cancer.

Rosati R, Adil MR, Ali MA, Eliason J, Orosz A, Sebestyén F, Kalemkerian GP. Rosati R, et al. Among authors: kalemkerian gp. Peptides. 1998;19(9):1519-23. doi: 10.1016/s0196-9781(98)00116-8. Peptides. 1998. PMID: 9864058

8

Activity of 9-cis-retinoic acid and receptor-selective retinoids in small cell lung cancer cell lines.

Rosati R, Ramnath N, Adil MR, Ou X, Ali MA, Heyman RA, Kalemkerian GP. Rosati R, et al. Among authors: kalemkerian gp. Anticancer Res. 1998 Nov-Dec;18(6A):4071-5. Anticancer Res. 1998. PMID: 9891447

9

Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines.

Kalemkerian GP, Ou X. Kalemkerian GP, et al. Cancer Chemother Pharmacol. 1999;43(2):145-50. doi: 10.1007/s002800050875. Cancer Chemother Pharmacol. 1999. PMID: 9923820

10

Activity of dolastatin 10 against small-cell lung cancer in vitro and in vivo: induction of apoptosis and bcl-2 modification.

Kalemkerian GP, Ou X, Adil MR, Rosati R, Khoulani MM, Madan SK, Pettit GR. Kalemkerian GP, et al. Cancer Chemother Pharmacol. 1999;43(6):507-15. doi: 10.1007/s002800050931. Cancer Chemother Pharmacol. 1999. PMID: 10321512

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

150 results

Search Page

Filters